MedPath

Stress Management for High Blood Pressure

Not Applicable
Conditions
Prehypertension
Registration Number
NCT02371317
Lead Sponsor
Kent State University
Brief Summary

The purpose of this research study is to examine the efficacy of two stress management interventions in reducing blood pressure (BP) in patients who have prehypertension (BP between 120/80 and 139/89). It is expected that participants will be better able to control their BP through reducing stress and increasing healthy lifestyle behaviors.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
141
Inclusion Criteria
  • Unmedicated high blood pressure (SBP of 120-139 or DBP of 80-89)
  • BMI in the range of 19-40
  • Interest in attempting to control blood pressure through lifestyle modification
Exclusion Criteria
  • pacemakers
  • uncontrolled hypertension (SBP≥140 or DBP≥90)
  • atrial fibrillation
  • myocardial infarction (MI)
  • percutaneous transluminal coronary angioplasty (PTCA)
  • coronary artery bypass graft (CABG) within 6 months of enrollment
  • congestive heart failure
  • uncorrected primary valvular disease hypertrophic or restrictive cardiomyopathy
  • uncorrected thyroid heart disease
  • chronic kidney disease
  • persistent tachyarrhythmia
  • JNC risk category C (target organ damage, diabetes)
  • patients who are pregnant or plan to become pregnant within 9 months
  • patients who are lactating
  • patients unable to comply with assessment procedures
  • patients with alcohol or drug abuse within 12 months
  • patients who consume more than 21 alcoholic drinks per week
  • patients who are current smokers
  • patients who are unable to provide informed consent or who have dementia
  • patients with previous extensive meditation or yoga training
  • patients with blood pressure ≥140/90

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Change in Systolic Clinic Blood PressureWeek 0, Week 4, Week 8, Week 34, and Week 60

All clinic blood pressure assessments will be completed in a quiet, climate controlled room according to American Heart Association guidelines. The mean of the three seated readings on the non- dominant arm will be averaged to define clinic blood pressure.

Change in Diastolic Clinic Blood PressureWeek 0, Week 4, Week 8, Week 34, and Week 60

All clinic blood pressure assessments will be completed in a quiet, climate controlled room according to American Heart Association guidelines. The mean of the three seated readings on the non- dominant arm will be averaged to define clinic blood pressure.

Secondary Outcome Measures
NameTimeMethod
Change in 24-hour Ambulatory Systolic Blood PressureWeek 0, Week 8, Week 60

Participants will complete 24-hour Ambulatory Blood Pressure Monitoring with the Oscar 2 oscillometric blood pressure monitor. The Oscar will be programmed to take three blood pressure measurements per hour from 6 AM till 11 PM and two BP measurements per hour from 11 PM to 6 AM. During each reading, participants will be instructed to drop their arms to their sides as soon as they sense the cuff inflating, and to keep it relaxed and still until a few seconds after the deflation has finished. Ambulatory SBP and DBP will be derived by computing the mean of all valid readings obtained during waking hours and nighttime sleep.

Change in 24-hour Ambulatory Diastolic Blood PressureWeek 0, Week 8, Week 60

Participants will complete 24-hour Ambulatory Blood Pressure Monitoring with the Oscar 2 oscillometric blood pressure monitor. The Oscar will be programmed to take three blood pressure measurements per hour from 6 AM till 11 PM and two BP measurements per hour from 11 PM to 6 AM. During each reading, participants will be instructed to drop their arms to their sides as soon as they sense the cuff inflating, and to keep it relaxed and still until a few seconds after the deflation has finished. Ambulatory SBP and DBP will be derived by computing the mean of all valid readings obtained during waking hours and nighttime sleep.

Trial Locations

Locations (2)

W.O. Walker Building

🇺🇸

Cleveland, Ohio, United States

University of Pennsylvania Perelman School of Medicine

🇺🇸

Philadelphia, Pennsylvania, United States

W.O. Walker Building
🇺🇸Cleveland, Ohio, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.